Disease Studies

UK BioIndustry Association launches first TechBio company report


OXFORD, UK: PrecisionLife featured as a case study of how a data-driven techbio company is transforming drug discovery and patient care

BioIndustry Association launches first TechBio report

The BioIndustry Association (BIA), the trade association for innovative life sciences in the UK, has launched its first report on the UK TechBio industry.

The report introduces and explains the impact that data-driven life sciences companies are having on drug discovery and patient care. It features case studies on six leading TechBio companies, including PrecisionLife.

Data-driven life sciences companies work at the interface between biotechnology and technology. They combine cutting-edge techniques from both sectors to draw insights from a wealth of data, including data concerning patients, drug molecules, healthcare infrastructure and research and development, to inform and transform drug discovery and patient care.

Included in the report are:

  • Opportunities and obstacles for data-driven life sciences companies
  • Highlights of data-driven life sciences and techbio company successes
  • Predictions of how data-driven life sciences and technology companies could transform the health ecosystem by 2025

Dr Steve Gardner, CEO, PrecisionLife: “A biology revolution is coming. There will be a fundamental shift in the level of detail at which you can understand complex chronic diseases that cover 85% of spending in healthcare. At PrecisionLife we turn data into understand of what’s driving disease and insights that enable the discovery, development, and delivery of more effective personalised treatments. We’re proud to be a leading techbio company and to have our achievements recognised in this report.”

Lord David Prior, Chairman, NHS England: “Transforming the future of healthcare will rest on the new technologies and therapies emerging within the life sciences sector. Developing the innovations we are seeing in data-driven life sciences technology will be pivotal as we transform drug discovery pathways and patient care.”

Steve Bates, CEO, UK BioIndustry Association: “Data-driven life sciences technology, or techbio, is an area where the BIA is rapidly building its expertise. This report introduces the exciting companies that are working at the interface of biotechnology and technology and shows how they are already making an impact on drug discovery and patient care.”

Read the TechBio company report

About PrecisionLife

PrecisionLife is a TechBio company driving precision medicine in chronic diseases. We focus on patients to enable high-value biological insights that improve understanding of complex diseases in areas of unmet medical need. Our unique combinatorial analytics is revolutionizing the discovery, development, and delivery of medicine to create better, more personalized therapy options so people can live longer, healthier lives.

More News & Media

View All News & Media

PrecisionLife Wins Analytics Company of the Year at British Data Awards

PrecisionLife named Analytics Company of the Year at awards ceremony in London

Read more

#850Challenge for kidney disease research

PrecisionLife has teamed up with Kidney Research UK, the BioIndustry Association and its members to raise funds and awareness…

Read more

PrecisionLife and Sano Genetics announce partnership to accelerate understanding of long COVID and help identify new treatments

A new partnership between PrecisionLife and Sano Genetics will help advance researchers’ understanding of the drivers of long COVID,…

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.